Bilateral tinnitus, also known as tinnitus in both ears or ringing in both ears, is characterized by the perception of noise, such as ringing, buzzing, or hissing, in both ears. This page explores bilateral ear noise causes, diagnosis, clinical documentation best practices, and relevant medical coding (ICD-10) for healthcare professionals. Learn about managing and treating bilateral tinnitus for improved patient care.
Perception of sound (ringing, buzzing, hissing) in both ears without an external source.
Phantom noise in both ears, often described as ringing, buzzing, hissing, clicking, or whooshing. May vary in pitch and loudness.
Primary care clinics, audiology departments, ENT clinics, tinnitus clinics.
Complete code families applicable to H93.13
| Description | When to use |
|---|---|
| Ringing in both ears | Use for tinnitus perceived in both ears. Commonly used, patient-friendly term. |
| Ringing in one ear | Use for tinnitus localized to a single ear. Specify left or right ear if known. Important for lateralization. |
| Pulsatile tinnitus | Use when tinnitus is rhythmic or pulsating, often synchronous with heartbeat. Requires further investigation. |
Incorrectly coding tinnitus laterality (e.g., using unilateral codes for bilateral tinnitus) can lead to inaccurate billing and claims rejection. ICD-10-CM coding guidelines for laterality must be followed.
Failing to specify the tinnitus subtype (e.g., subjective vs. objective) when documented can affect reimbursement. Complete documentation is crucial for accurate coding (H93.1).
Not coding the underlying cause of tinnitus, when known, can lead to underreporting of comorbid conditions and potentially impact quality metrics and risk adjustment (e.g. Meniere's disease).
Confirm bilateral presentation: patient reports tinnitus in both ears.
Exclude unilateral causes: impacted cerumen, TM perforation, acoustic neuroma.
Assess tinnitus characteristics: onset, duration, character, impacting factors.
Evaluate comorbidities: hearing loss, hypertension, head injury, ototoxic meds.
Document laterality, characteristics, and associated factors for accurate coding.
Patient presents with bilateral tinnitus, characterized by a subjective perception of ringing in both ears. The patient denies pulsatile tinnitus, hearing loss, vertigo, or ear pain. Onset was gradual and the patient is unable to identify any specific triggers. The tinnitus is described as a constant, high-pitched ringing sound that is more noticeable in quiet environments and interferes with sleep and concentration. Otoscopic examination reveals normal bilateral tympanic membranes and external auditory canals. Pure-tone audiometry demonstrates normal hearing thresholds bilaterally. The differential diagnosis includes noise-induced hearing loss, Meniere's disease, acoustic neuroma, and temporomandibular joint disorder. Given the absence of other otologic symptoms and normal audiometry, the diagnosis of bilateral tinnitus is made. Patient education regarding tinnitus management strategies, including sound therapy and cognitive behavioral therapy, was provided. Follow-up is recommended if symptoms worsen or new symptoms develop. ICD-10 code H93.19 (Other tinnitus) is assigned. This diagnosis may be further specified with additional codes for laterality and etiology if clinically indicated. Treatment plan focuses on improving quality of life and mitigating the impact of tinnitus on daily activities.
Differentiating between subjective and objective tinnitus is crucial for effective management. For subjective bilateral tinnitus, a thorough history focusing on onset, characteristics (e.g., pulsatile, high-pitched, low-pitched), exacerbating and alleviating factors, and associated symptoms (hearing loss, vertigo, pain) is paramount. Audiometric evaluation, including pure-tone audiometry, speech audiometry, and tympanometry, helps identify potential underlying hearing loss. Otoacoustic emissions testing can help assess cochlear function. For suspected objective tinnitus, consider auscultation for vascular bruit, imaging studies like MRI or CT to rule out vascular abnormalities or tumors, and referral to an otolaryngologist for specialized assessments like vestibular evoked myogenic potentials (VEMPs) to evaluate for superior canal dehiscence. Explore how integrating these diagnostic procedures can refine your clinical approach to bilateral tinnitus.
While noise-induced hearing loss is a common cause of bilateral tinnitus, careful evaluation is needed to exclude other conditions. A detailed patient history, including occupational noise exposure, medication use (e.g., ototoxic drugs like aspirin, certain antibiotics), presence of vertigo or balance issues (suggestive of Meniere's disease), and jaw pain or clicking (indicating TMJ issues), is essential. Audiometric testing often reveals a characteristic notched pattern of hearing loss in noise-induced tinnitus. In contrast, ototoxicity can present with various audiometric patterns depending on the specific drug. Meniere's disease often involves fluctuating hearing loss, episodic vertigo, and aural fullness. TMJ disorders may present with referred pain to the ear and can be evaluated by a dentist or oral surgeon. Consider implementing a structured clinical pathway to systematically differentiate these etiologies and guide appropriate management for bilateral tinnitus.
Managing persistent bilateral tinnitus, especially in patients unresponsive to sound therapy, requires a multimodal approach. While no single pharmacological treatment is universally effective, certain medications, such as antidepressants (e.g., amitriptyline) and anxiolytics, can help manage associated mood disturbances and sleep difficulties. Cognitive-behavioral therapy (CBT) has shown efficacy in reducing tinnitus-related distress and improving quality of life. Tinnitus retraining therapy (TRT) can help patients habituate to the tinnitus perception. Other non-pharmacological options include sound generators, mindfulness-based stress reduction, and support groups. For patients with significant hearing loss, hearing aids can provide both auditory stimulation and amplification, potentially reducing tinnitus perception. Learn more about how combining these pharmacological and non-pharmacological strategies can provide comprehensive tinnitus management for your patients.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.